Phaseline

Companies › The United Bio-Technology (Hengqin)

The United Bio-Technology (Hengqin): clinical trials, targets and expected readouts

3 active drug programs in 8 registered trials: 3 Phase 3, 3 Phase 1, 2 Phase 2; Metabolic and endocrine, Genitourinary; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
UBT251 Injection
GLP-1 receptor agonist
–Phase 3Type 2 Diabetes; Obesity & Overweight; Metabolic Dysfunction-associated Steatohepatitis (MASH); Obesity &Amp; Overweight …Dec 2026
UBT37034–Phase 1Overweight , ObesityAug 2027
UBT38006–Phase 1Type 2 Diabetes Mellitus (T2DM)–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07630233UBT38006Phase 1Type 2 Diabetes Mellitus (T2DM)Metabolic and endocrineOct 2026
NCT07785934UBT251 InjectionPhase 1Drug Drug Interaction (DDI)Metabolic and endocrineDec 2026
NCT07145151UBT251 InjectionPhase 2Metabolic Dysfunction-associated Steatohepatitis (MASH)Metabolic and endocrineJun 2027
NCT07873645UBT37034Phase 1Overweight , ObesityMetabolic and endocrineAug 2027
NCT07659574UBT251 InjectionPhase 3Type 2 DiabetesMetabolic and endocrineSep 2027
NCT07648225UBT251 InjectionPhase 3Obesity & OverweightMetabolic and endocrineSep 2027
NCT07653477UBT251 InjectionPhase 3Type 2 DiabetesMetabolic and endocrineFeb 2028
NCT07134335UBT251 InjectionPhase 2Obesity &Amp; OverweightGenitourinaryJul 2030

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Ascletis Pharma (China) JCR Pharmaceuticals Innovent Biologics Technology Limited (Shanghai R&D Center) Laekna Gan & Lee Pharmaceuticals.

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.